Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Forecasting determinants of recurrence in lung cancer patients exploiting various machine learning models.
J Biopharm Stat. 2023 May 4;33(3):257-271. doi: 10.1080/10543406.2022.2148162. Epub 2022 Nov 17.
J Biopharm Stat. 2023.
PMID: 36397284
Exploring safe and potent bioactives for the treatment of non-small cell lung cancer.
Thirunavukkarasu MK, Shin WH, Karuppasamy R.
Thirunavukkarasu MK, et al.
3 Biotech. 2021 May;11(5):241. doi: 10.1007/s13205-021-02797-6. Epub 2021 Apr 26.
3 Biotech. 2021.
PMID: 33968584
Free PMC article.
Item in Clipboard
Drug repurposing combined with MM/PBSA based validation strategies towards MEK inhibitors screening.
Thirunavukkarasu MK, Karuppasamy R.
Thirunavukkarasu MK, et al.
J Biomol Struct Dyn. 2022;40(22):12392-12403. doi: 10.1080/07391102.2021.1970629. Epub 2021 Aug 30.
J Biomol Struct Dyn. 2022.
PMID: 34459701
Item in Clipboard
In Silico Screening of Available Drugs Targeting Non-Small Cell Lung Cancer Targets: A Drug Repurposing Approach.
Thirunavukkarasu MK, Suriya U, Rungrotmongkol T, Karuppasamy R.
Thirunavukkarasu MK, et al.
Pharmaceutics. 2021 Dec 28;14(1):59. doi: 10.3390/pharmaceutics14010059.
Pharmaceutics. 2021.
PMID: 35056955
Free PMC article.
Item in Clipboard
Computational biophysics approach towards the discovery of multi-kinase blockers for the management of MAPK pathway dysregulation.
Thirunavukkarasu MK, Veerappapillai S, Karuppasamy R.
Thirunavukkarasu MK, et al.
Mol Divers. 2023 Oct;27(5):2093-2110. doi: 10.1007/s11030-022-10545-y. Epub 2022 Oct 19.
Mol Divers. 2023.
PMID: 36260173
Item in Clipboard
Sequential virtual screening collaborated with machine-learning strategies for the discovery of precise medicine against non-small cell lung cancer.
Thirunavukkarasu MK, Veerappapillai S, Karuppasamy R.
Thirunavukkarasu MK, et al.
J Biomol Struct Dyn. 2024 Jan-Feb;42(2):615-628. doi: 10.1080/07391102.2023.2194994. Epub 2023 Mar 30.
J Biomol Struct Dyn. 2024.
PMID: 36995235
Item in Clipboard
Transcriptome profiling and metabolic pathway analysis towards reliable biomarker discovery in early-stage lung cancer.
Thirunavukkarasu MK, Ramesh P, Karuppasamy R, Veerappapillai S.
Thirunavukkarasu MK, et al.
J Appl Genet. 2024 Mar 5. doi: 10.1007/s13353-024-00847-2. Online ahead of print.
J Appl Genet. 2024.
PMID: 38443694
Item in Clipboard
Cite
Cite